Federal award
GEN-PROBE INCORPORATED
W91YTZ18P0363
Contract
Obligated and Ceiling
- Obligated (net)
- $873,312.00
- Ceiling (potential value, not spending)
- $873,312.01
- Current value
- $873,312.01
- Gross positive obligations
- $1,727,309.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- GEN-PROBE INCORPORATED · QNXWLAJDL4J3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- GEN-PROBE INCORPORATED · C5NDR1H6DJY4
- Awarding agency
- Department of War · sub-agency 2100 · office W91YTZ
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W91YTZ18P0363
- Award type code
- B
- Actions
- 22 · Sep 21, 2018 to Dec 5, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History22
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Dec 5, 2023 | FY2024 | P00021 | C | −$74,648.50 | — |
| May 30, 2023 | FY2023 | P00020 | C | −$34,687.50 | — |
| Apr 6, 2023 | FY2023 | P00019 | C | −$129,925.00 | — |
| Jan 23, 2023 | FY2023 | P00018 | C | −$90,000.00 | — |
| Oct 7, 2022 | FY2023 | P00017 | C | $278,550.00 | — |
| Jul 8, 2022 | FY2022 | P00016 | C | −$65,462.00 | — |
| Jun 6, 2022 | FY2022 | P00015 | G | $0.00 | — |
| Oct 21, 2021 | FY2022 | P00014 | C | $278,550.00 | — |
| Aug 11, 2021 | FY2021 | P00013 | G | $0.00 | — |
| Jul 30, 2021 | FY2021 | P00012 | C | −$280,837.00 | — |
| Mar 19, 2021 | FY2021 | P00011 | B | $2,988.00 | — |
| Jan 7, 2021 | FY2021 | P00010 | C | $275,562.00 | — |
| Nov 2, 2020 | FY2021 | P00009 | M | $0.00 | — |
| Jun 10, 2020 | FY2020 | P00008 | B | $314,410.00 | — |
| Jun 9, 2020 | FY2020 | P00007 | D | $3,000.00 | — |
| Jun 5, 2020 | FY2020 | P00006 | C | $23,125.00 | — |
| Jun 1, 2020 | FY2020 | P00005 | G | $0.00 | — |
| Feb 29, 2020 | FY2020 | P00004 | C | −$178,437.00 | — |
| Oct 22, 2019 | FY2020 | P00003 | C | $275,562.00 | — |
| Aug 14, 2019 | FY2019 | P00002 | G | $0.00 | — |
| Oct 30, 2018 | FY2019 | P00001 | C | $275,562.00 | — |
| Sep 21, 2018 | FY2018 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.